The Coca-Cola Company has reported a 16% rise in third-quarter net revenue and raised its guidance for full-year organic revenue growth.
The company – which owns major beverage brands including Coca-Cola, Sprite and VitaminWater – posted Q3 revenue of $10 billion, compared with last year’s $8.7 billion figure. Meanwhile, operating income grew 26% in the quarter.
Coca-Cola has updated its full-year guidance “to reflect another quarter of momentum in the business” and says that it now expects to deliver organic revenue growth of 13-14%.
Global unit case volume – a key indicator of demand – grew 6% year-over-year, benefitting from ongoing recovery in markets where coronavirus-related uncertainty is abating. The average value of products sold also rose 6%.
In Q3, Europe, Middle East & Africa unit case volume grew 8%. The company’s Latin American division saw volume go up 8%, while it went up 4% in North America, 3% in Asia Pacific and 3% in Coca-Cola’s bottling investments segment.
Unit case volume of sparkling soft drinks grew 6% in the quarter, driven by strong performance across all geographic operating segments.
Nutrition, juice, dairy and plant-based beverages grew 12%, underpinned by a “solid performance” from Minute Maid Pulpy in China, Maaza in India and Del Valle in Mexico.
Hydration, sports, coffee and tea saw unit case volume grow 6%. Coffee grew 19%, primarily driven by the ongoing reopening of Costa retail stores in the UK.
“Our strategic transformation is enabling us to effectively navigate a dynamic environment and emerge stronger from the pandemic,” said James Quincey, chairman and CEO of The Coca-Cola Company.
“While the recovery continues to be asynchronous around the world, we are investing for growth to drive long-term value for the system.”
By Antonia Garrett Peel
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.